Rigel Pharmaceuticals Inc (RIGL)

Income Tax Expense

$6.30M

Quarterly · Period ending: · USD

RIGL logo

RIGL Income Tax Expense

Latest reported$6.30M
RIGL Quarterly Income Tax ($6.53M → $6.30M)
High-resolution chart · PNG

RIGL income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
6,295,000
3,003,000
-245,351,000
-280,000
369,000
65,000
881,000
0
0
0
0
0
0
0
0
0
0
0
-60,000
-136,000
-970,000
1,771,000
0
0
0
0
0
0
0
0
0
-159,000
0
0
-113,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-73,368,000
0
0
0
-42,255,000
114,000
0
0
90,000
-327,000
76,000
47,000
93,000
0
-27,000
-66,000
-4,368,000
0
0
0
-55,270,000
0
0
0
-22,181,000
0
0
0
-36,363,000
0
0
0
-612,000
0
0
0
-29,335,000
0
0
0
-28,960,000
0
0
0
-17,694,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.